STKE vs SMLR

Semler Scientific, Inc.

(SMLR) offers the better valuation at 4. 0x trailing P/E, making it the more compelling value choice. Analysts rate Semler Scientific, Inc. (SMLR) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Semler Scientific, Inc.

(SMLR) is the cheapest at 4. 0x versus Sol Strategies Inc. Common Shares at 6. 6x.

Over the past 5 years, Semler Scientific, Inc.

(SMLR) delivered a total return of -81. 8%, compared to -81. 9% for Sol Strategies Inc. Common Shares (STKE). Over 10 years, the gap is even starker: SMLR returned +1110% versus STKE's -81. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Semler Scientific, Inc.

(SMLR) is the lower-risk stock at 2. 48β versus Sol Strategies Inc. Common Shares's 3. 61β — meaning STKE is approximately 46% more volatile than SMLR relative to the S&P 500.

On earnings-per-share growth, the picture is similar: Sol Strategies Inc.

Common Shares grew EPS 200. 0% year-over-year, compared to 95. 1% for Semler Scientific, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Semler Scientific, Inc.

(SMLR) is the more profitable company, earning 72. 7% net margin versus 0. 0% for Sol Strategies Inc. Common Shares — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMLR leads at 37. 2% versus 0. 0% for STKE. At the gross margin level — before operating expenses — SMLR leads at 91. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Semler Scientific, Inc.

(SMLR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1110% 10Y return). Sol Strategies Inc. Common Shares (STKE) carries a higher beta of 3. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMLR: +1110%, STKE: -81. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (STKE (Financial Services) and SMLR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.